SEC Form 4 · accession 0001209191-17-065420

HERBALIFE LTD. · HLF

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Executive Chairman · Director

Period of report

Dec 11, 2017

Accepted (ET)

Dec 13, 2017 · 4:16 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001180262

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Dec 11, 2017	M	132,416	$22.94	A	2,080,700	D
Common Stock	Dec 11, 2017	D	43,513	$69.81	D	2,037,187	D
Common Stock	Dec 11, 2017	F	49,120	$69.81	D	1,988,067	D
Common Stock	Dec 11, 2017	M	210,648	$53.29	A	2,198,715	D
Common Stock	Dec 11, 2017	D	160,800	$69.81	D	2,037,915	D
Common Stock	Dec 11, 2017	F	27,542	$69.81	D	2,010,373	D
Common Stock	Dec 11, 2017	M	327,868	$44.79	A	2,338,241	D
Common Stock	Dec 11, 2017	D	210,360	$69.81	D	2,127,881	D
Common Stock	Dec 11, 2017	F	64,924	$69.81	D	2,062,957	D
Common Stock	holding	—	—		—	35,340	I	Beneficially owned through a trust for his child
Common Stock	holding	—	—		—	113,122	I	Beneficially owned through Michael O. Johnson IRA

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Stock Appreciation Right	$22.94	Dec 11, 2017	M	132,416	D	May 7, 2013	May 7, 2020	Common Stock	132,416	D
Stock Appreciation Right	$53.29	Dec 11, 2017	M	210,648	D	May 18, 2014	May 18, 2021	Common Stock	210,648	D
Stock Appreciation Right	$44.79	Dec 11, 2017	M	327,868	D	May 31, 2015	May 31, 2022	Common Stock	327,868	D

F1The reporting person received 39,783 shares of common stock upon the net exercise of 132,416 stock appreciation rights ("SARS"). The reporting person forfeited 43,513 shares of common stock underlying such SARS in payment of the exercise price and 49,120 shares of common stock underlying such SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on December 11, 2017 of $69.81.
F2The reporting person received 22,306 shares of common stock upon the net exercise of 210,648 SARS. The reporting person forfeited 160,800 shares of common stock underlying such SARS in payment of the exercise price and 27,542 shares of common stock underlying such SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on December 11, 2017 of $69.81.
F3The reporting person received 52,584 shares of common stock upon the net exercise of 327,868 SARS. The reporting person forfeited 210,360 shares of common stock underlying such SARS in payment of the exercise price and 64,924 shares of common stock underlying such SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on December 11, 2017 of $69.81.